Skip to main content
Erschienen in: Investigational New Drugs 6/2009

01.12.2009 | PRECLINICAL STUDIES

Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study

verfasst von: S. B. Benaka Prasad, K. Vinaya, C. S. Ananda Kumar, Sanjay Swarup, K. S. Rangappa

Erschienen in: Investigational New Drugs | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Summary

A series of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives 5(a–m) were synthesized with different substituted aromatic/heterocyclic acid chlorides (R-CO-Cl) and characterized by 1H NMR, LC/MS, FTIR and elemental analyses. All the compounds synthesised were evaluated for their antiproliferative activity by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The antiproliferative effects of the synthesised compounds were tested against viable human skin fibroblast cells and carcinoma cells namely HeLa cells, HT-29 cells, MCF-7 cells, HepG-2 cells by adopting positive and negative control. The importance of the aromatic and heterocyclic moiety was confirmed. From the SAR studies, it reveals that, the substitution at N-terminal of 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole by the heterocyclic ring plays a dominant role and was responsible for the antiproliferative activity. Among the synthesized compounds 5a, 5d and 5k have showed potent antiproliferative activity on all the carcinoma cells tested.
Literatur
6.
Zurück zum Zitat Kirk KL, Filler R (1996) In Biomedical Frontiers of Fluorine Chemistry, Symposium Series, vol 639. American Chemical Society, Washington, DC, pp 1–24. Kirk KL, Filler R (1996) In Biomedical Frontiers of Fluorine Chemistry, Symposium Series, vol 639. American Chemical Society, Washington, DC, pp 1–24.
7.
8.
Zurück zum Zitat Dollery C (1999) Therapeutic drugs. Churchill Livingstone, Edinburgh, UK Dollery C (1999) Therapeutic drugs. Churchill Livingstone, Edinburgh, UK
10.
Zurück zum Zitat Deng BL, Cullen MD, Zhou Z, Hartman TL, Buckheit RW Jr, Pannecouque C, Clercq ED, Fanwick PE, Cushmana M (2006) Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings. Bioorg Med Chem 14:2366–2374. doi:10.1016/j.bmc.2005.11.014 CrossRefPubMed Deng BL, Cullen MD, Zhou Z, Hartman TL, Buckheit RW Jr, Pannecouque C, Clercq ED, Fanwick PE, Cushmana M (2006) Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings. Bioorg Med Chem 14:2366–2374. doi:10.​1016/​j.​bmc.​2005.​11.​014 CrossRefPubMed
11.
13.
Zurück zum Zitat Nuhrich A, Lembege MV, Vercauteren J, Dokhan R, Renard P, Devaux G (1996) Synthesis and binding affinities of a series of 1,2-benzisoxazole-3-carboxamides to dopamine and serotonin receptors. Eur J Med Chem 31:957–964. doi:10.1016/S0223-5234(97)86174-0 CrossRef Nuhrich A, Lembege MV, Vercauteren J, Dokhan R, Renard P, Devaux G (1996) Synthesis and binding affinities of a series of 1,2-benzisoxazole-3-carboxamides to dopamine and serotonin receptors. Eur J Med Chem 31:957–964. doi:10.​1016/​S0223-5234(97)86174-0 CrossRef
14.
Zurück zum Zitat Stiff DD, Robicheau JT, Zemaitis MA (1992) Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. Xenobiotica 22(1):1–11CrossRefPubMed Stiff DD, Robicheau JT, Zemaitis MA (1992) Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. Xenobiotica 22(1):1–11CrossRefPubMed
15.
Zurück zum Zitat Clive BP, Scott ES, Phillip SS, Michael RK (1999) Synthesis and evaluation of 6-[11C]Methoxy-3-[2- [1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2-benzisoxazole as an in vivo radioligand for acetylcholinesterase. Nucl Med Biol 26(1):99–103. doi:10.1016/S0969-8051(98)00078-X CrossRef Clive BP, Scott ES, Phillip SS, Michael RK (1999) Synthesis and evaluation of 6-[11C]Methoxy-3-[2- [1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2-benzisoxazole as an in vivo radioligand for acetylcholinesterase. Nucl Med Biol 26(1):99–103. doi:10.​1016/​S0969-8051(98)00078-X CrossRef
16.
Zurück zum Zitat Priya BS, Basappa, Swamy SN, Rangappa KS (2005) Synthesis and characterization of novel 6-fluoro-4-piperidinyl-1,2-benzisoxazole amides and 6-fluoro-chroman-2-carboxamides: antimicrobial studies. Bioorg Med Chem 13(7):2623–2628. doi:10.1016/j.bmc.2005.01.026 CrossRefPubMed Priya BS, Basappa, Swamy SN, Rangappa KS (2005) Synthesis and characterization of novel 6-fluoro-4-piperidinyl-1,2-benzisoxazole amides and 6-fluoro-chroman-2-carboxamides: antimicrobial studies. Bioorg Med Chem 13(7):2623–2628. doi:10.​1016/​j.​bmc.​2005.​01.​026 CrossRefPubMed
17.
Zurück zum Zitat Chandrappa S, Benaka Prasad SB, Vinaya K, Ananda Kumar CS, Thimmegowda NR, Rangappa KS (2008) Synthesis and In vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones. Invest New Drugs 26:437–444. doi:10.1007/s10637-008-9130-7 CrossRefPubMed Chandrappa S, Benaka Prasad SB, Vinaya K, Ananda Kumar CS, Thimmegowda NR, Rangappa KS (2008) Synthesis and In vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones. Invest New Drugs 26:437–444. doi:10.​1007/​s10637-008-9130-7 CrossRefPubMed
18.
Zurück zum Zitat Ananda Kumar CS, Benaka Prasad SB, Vinaya K, Chandrappa S, Thimmegowda NR Sanjay Swarup, Rangappa KS (2008) Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study. Invest New Drugs. doi:10.1007/s10637-008-9150-3. Ananda Kumar CS, Benaka Prasad SB, Vinaya K, Chandrappa S, Thimmegowda NR Sanjay Swarup, Rangappa KS (2008) Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study. Invest New Drugs. doi:10.​1007/​s10637-008-9150-3.
19.
Zurück zum Zitat Ananda Kumar CS, Nanjunda Swamy S, Thimmegowda NR, Benaka Prasad SB, George WY, Rangappa KS (2007) Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Med Chem Res 16:179–187. doi:10.1007/s00044-007-9022-y CrossRef Ananda Kumar CS, Nanjunda Swamy S, Thimmegowda NR, Benaka Prasad SB, George WY, Rangappa KS (2007) Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Med Chem Res 16:179–187. doi:10.​1007/​s00044-007-9022-y CrossRef
20.
Zurück zum Zitat Ananda Kumar CS, Kavitha CV, Vinaya K, Benaka Prasad SB, Thimmegowda NR, Chandrappa S, Sathees CR, Rangappa KS (2008) Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study. Invest New Drugs. doi:10.1007/s10637-008-9179-3 Ananda Kumar CS, Kavitha CV, Vinaya K, Benaka Prasad SB, Thimmegowda NR, Chandrappa S, Sathees CR, Rangappa KS (2008) Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study. Invest New Drugs. doi:10.​1007/​s10637-008-9179-3
21.
Zurück zum Zitat Basappa, Mantelingu K, Sadashiva MP, Rangappa KS (2004) A simple and efficient method for the synthesis 1,2-benzisoxazoles: a series of its potent acetylcholinesterase inhibitors. Indian J Chem 43(B):1954–1957 Basappa, Mantelingu K, Sadashiva MP, Rangappa KS (2004) A simple and efficient method for the synthesis 1,2-benzisoxazoles: a series of its potent acetylcholinesterase inhibitors. Indian J Chem 43(B):1954–1957
22.
Zurück zum Zitat Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seni D, Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833PubMed Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seni D, Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833PubMed
Metadaten
Titel
Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study
verfasst von
S. B. Benaka Prasad
K. Vinaya
C. S. Ananda Kumar
Sanjay Swarup
K. S. Rangappa
Publikationsdatum
01.12.2009
Verlag
Springer US
Erschienen in
Investigational New Drugs / Ausgabe 6/2009
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-008-9205-5

Weitere Artikel der Ausgabe 6/2009

Investigational New Drugs 6/2009 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.